We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eirx Therap. | LSE:ERX | London | Ordinary Share | GB00B0XQBS97 | ORD 0.001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.015 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
30/4/2014 21:49 | Where's Mike D with his update..... | blueblood | |
22/4/2014 17:58 | May I be the first to wish all readers a Happy Christmas for 2014. | downham21 | |
14/4/2014 16:02 | Ian impatient lol!! You must be a Saint then downham21 | nico9 | |
13/4/2014 08:30 | This time next year Rodney...LOL.. | never_say_never | |
13/4/2014 08:24 | Ian - you are too impatient - all will be revealed. | downham21 | |
12/4/2014 22:13 | What's going on? | ian l | |
08/4/2014 17:29 | I think they are going to buy Tiziana pharma! | stenick | |
08/4/2014 13:59 | Those that say the're in the 'know' are not in the know. Give this up - A third pre ipo would be an astonishing cheek. Mind you, I'd go for it : | ewads | |
08/4/2014 12:04 | Does anyone in the 'know' know if anything is being done to try and relist this company? I keep looking at the website for the regular updates, but my computer must be playing up, because I cant see any updates. | bricket | |
08/4/2014 11:34 | Thank you one and all, for all your inspiring words. | alby220 | |
07/4/2014 15:53 | From the ones who gave you the two recent episodes... "project plan 1 and project plan 2: towards the difficult route to market" (a few years ago) ...... Following the first premiere: "it's all about a rat that felt a bit better!" Others have said that this funding avenue was dead!. Coming soon to a BB near here. ....."Pre IPO funding No. 3!"... The final countdown to deliver something for SH's. | officerdigby | |
07/4/2014 15:23 | indeed Knowing we are in others hands. | the_alchemist | |
07/4/2014 15:12 | Alby do not give up hope. Like you I am really really keen for the Company to say something but if they have nothing to say yet then it is better they wait until there is is something they can say,rather than saying "there is nothing we can say right now" . I am hopeful this will all come good and I think if the BOD pull of a relist they will deserve a huge accolade. The shareholders too need to be congratulated for keeping faith over a very long period of suspension. | the_alchemist | |
07/4/2014 14:49 | This cannot go on much longer, with absolutely no info as to progress surely ?? | alby220 | |
23/3/2014 21:08 | 23 Mar'14 - 20:57 - 2982 of 2982 0 0 MORE FROM TODAYS SUNDAY TIMES. " There is a palpable sense that British investors are re-discovering a taste for biotech stocks, which have not been in favour for years. Last week's float of Circassia, which is developing treatments to prevent allergic reaction to cats and pollen, is a sure sign these stocks are coming back into vogue" | share_shark | |
22/3/2014 17:17 | I think these things can take longer than anyone ever imagines . We have been told the website will be updated when there is news. I trust our BOD. Hopefully we will here something soon. This is not over yet. | the_alchemist | |
21/3/2014 19:42 | I think the have spent all the money and now are just letting it ride. | stenick | |
06/3/2014 12:09 | Is there a time table of events for the company? ie bank dispute resolution? interim results? | noddie dealer | |
28/2/2014 08:43 | wrong thread I think? | lundylou | |
25/2/2014 11:00 | Clutching Straws At DYOR | knowing | |
25/2/2014 10:01 | Until the directors lose capacity to write results/memory of company's existence/OR worse. | officerdigby |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions